Bio-Rad Laboratories, Inc.
BIO· NYSE
BIOBio-Rad Laboratories, Inc.
Filed Apr 29, 2022 · 10-Q · 29 days after period end · 0000012208-22-000026
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $700.06M | $726.80M | $571.64M | $553.98M |
| Net Income | -$3.37B | $980.00M | $685.90M | $865.20M |
| EPS Diluted | -$112.50 | $32.46 | $22.72 | $28.74 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed Apr 29, 2022 · 29 d after period end
